Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

CFDA Issues Guidance on Quality Control, Product Inspection

  • Post author:Sam
  • Post published:February 10, 2017
  • Post category:The GMP Letter

The China Food and Drug Administration (CFDA) has issued new guidance on quality control, finished product inspection, and other procedures for medical devices Source: The GMP Letter

Continue ReadingCFDA Issues Guidance on Quality Control, Product Inspection

FDA, DHS Warn of Cyber Vulnerabilities in St. Jude Cardiac Devices

  • Post author:Sam
  • Post published:February 10, 2017
  • Post category:The GMP Letter

The FDA and the Department of Homeland Security have flagged cybersecurity weaknesses in some St. Jude Medical implantable cardiac devices used with the company’s Merlin@home transmitters. Source: The GMP Letter

Continue ReadingFDA, DHS Warn of Cyber Vulnerabilities in St. Jude Cardiac Devices

Hong Kong Issues Warnings for Pacing Leads, Stents, Ventilators

  • Post author:Sam
  • Post published:January 18, 2017
  • Post category:The GMP Letter

Hong Kong’s Department of Heath issued safety warnings for Boston Scientific Ingevity MRI endocardial pacing leads and Percuflex Urinary Diversion stents, Draeger Medical GmbH Oxylog 3000 and Oxylog 3000plus ventilators,…

Continue ReadingHong Kong Issues Warnings for Pacing Leads, Stents, Ventilators

United Contact Lens Cited for Product Testing, Procedures

  • Post author:Sam
  • Post published:January 18, 2017
  • Post category:The GMP Letter

United Contact Lens received a warning letter for failing to test finished products and establish written customer complaint procedures. Source: The GMP Letter

Continue ReadingUnited Contact Lens Cited for Product Testing, Procedures

Numerous Procedural Violations Leads to Form 483 for Hoggan Scientific

  • Post author:Sam
  • Post published:January 18, 2017
  • Post category:The GMP Letter

Hoggan Scientific LLC was hit with a Form 483 after an inspection revealed a lack of adequate procedures for design control, corrective and preventive actions, complaint evaluation, and other issues.…

Continue ReadingNumerous Procedural Violations Leads to Form 483 for Hoggan Scientific

FDA Releases Final Guidance on Endoscope Cross-Contamination

  • Post author:Sam
  • Post published:January 18, 2017
  • Post category:The GMP Letter

Final guidance on reducing cross-contamination from irrigation valves and accessories for flexible gastrointestinal endoscopes adds a new section on testing for backflow prevention. Source: The GMP Letter

Continue ReadingFDA Releases Final Guidance on Endoscope Cross-Contamination

CryoSurgery Hit With Form 483 for Acceptance, Quality Procedures

  • Post author:Sam
  • Post published:January 18, 2017
  • Post category:The GMP Letter

CryoSurgery Inc. landed a Form 483 for poorly documented acceptance activities and inadequate procedures for ensuring the quality of received products. Source: The GMP Letter

Continue ReadingCryoSurgery Hit With Form 483 for Acceptance, Quality Procedures

Cures Act Encourages Breakthrough Devices, Exempts Medical Software

  • Post author:Sam
  • Post published:January 18, 2017
  • Post category:The GMP Letter

Manufacturing-related provisions in the recently enacted 21st Century Cures Act establish a program for “breakthough” devices, exempt some categories of medical software from regulation as a medical device, and require…

Continue ReadingCures Act Encourages Breakthrough Devices, Exempts Medical Software

Aesculap Gets Form 483 for Untimely Reports

  • Post author:Sam
  • Post published:January 18, 2017
  • Post category:The GMP Letter

Aesculap Inc. was cited in a Form 483 for neglecting to file timely medical device reportable (MDR) events and establish timely corrective and preventive actions in response to complaints. Source:…

Continue ReadingAesculap Gets Form 483 for Untimely Reports

Precision Interconnect Cited for Poor Documentation

  • Post author:Sam
  • Post published:January 18, 2017
  • Post category:The GMP Letter

Precision Interconnect was hit with a Form 483 for poor corrective and preventive action (CAPA) procedures and failing to ensure that products conformed to requirements. Source: The GMP Letter

Continue ReadingPrecision Interconnect Cited for Poor Documentation
  • Go to the previous page
  • 1
  • …
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.